|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| A61K 31/506 | |||
| A61K 31/517 | |||
| A61K 31/5377 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 35/04 |
| (11) | Number of the document | 2129376 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08727888.3 |
| Date of filing the European patent application | 2008-01-18 | |
| (97) | Date of publication of the European application | 2009-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/051406 |
| Date | 2008-01-18 |
| (87) | Number | WO 2008/089389 |
| Date | 2008-07-24 |
| (30) | Number | Date | Country code |
| 885728 P | 2007-01-19 | US |
| (72) |
WILHELM, Scott, US
GEDRICH, Richard W., US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (54) | Treatment of cancers with acquired resistance to KIT inhibitors |
| Treatment of cancers with acquired resistance to KIT inhibitors |